Lilly reports results of ANNOUNCE

Company |  News | 0 Comment | 21 Jan, 2019

Eli Lilly and Company has reported that the results of ANNOUNCE, the Phase 3 study of LARTRUVO (olaratumab), in combination with doxorubicin in patients with advanced or metastatic soft tis...Read more

AffordPlan remarks 300% growth in maternity patient base

Company |  News | 0 Comment | 21 Jan, 2019

AffordPlan, a first-of-its-kind financial technology platform that enables healthcare savings for individuals, registers an annual growth of 300 percent in maternity patient care. Set ...Read more

LupinLife to launch Corcal Bone & Beauty at LFW

Company |  News | 0 Comment | 21 Jan, 2019

LupinLife’s Corcal Bone & Beauty announces a collaboration with Lakme Fashion Week to celebrate #beautifullystrong women across India at the upcoming Lakme Fas...Read more

Sesderma to launch Dr. Serrano Clinics in India

Company |  News | 0 Comment | 18 Jan, 2019

Sesderma India recently organised a press conference in New Delhi. The company which is a subsidiary of Sesderma Laboratories headquartered in Valencia, Spain announce its plan of launching...Read more

Aurobindo Pharma’s subsidiary to acquire products from Spectrum Pharma

Company |  News | 0 Comment | 18 Jan, 2019

Aurobindo Pharma announces the signing of a definitive agreement to acquire a portfolio of seven branded oncology injectable products from Spectrum pharmaceuticals Inc. The acquisition also...Read more

Suven Life Sciences secures Product Patents in Australia and Singapore

Company |  News | 0 Comment | 17 Jan, 2019

Suven Life Sciences Ltd. has announced that the grant of one product patent from Australia and one product patent from Singapore corresponding to the New Chemical Entities for the treatment...Read more

Merck, Roche to renew global distribution agreement

Company |  News | 0 Comment | 15 Jan, 2019

Merck and Roche have agreed to renew their current distribution agreement for the Biochemical Reagents and Kapa Biosystems product portfolios, as well as select qPCR & Nu...Read more

Zydus receives USFDA approval for skin, heart drugs

Company |  News | 0 Comment | 14 Jan, 2019

Zydus Cadila has received the final approval from the USFDA to market Betamethasone Dipropionate Cream USP (US RLD – DIPROLENE® AF), 0.05%. It will be manufactured at the group&rs...Read more

Sun Pharma recalls anesthesia injection from US market

Company |  News | 0 Comment | 10 Jan, 2019

Sun Pharmaceutical Industries, Inc. (SPII), a wholly owned subsidiary of Sun Pharmaceutical Industries, Ltd. is voluntarily recalling three lots of Vecuronium Bromide for Injection, 10 mg (...Read more

Glenmark enters commercialization agreement for novel nasal spray

Company |  News | 0 Comment | 10 Jan, 2019

Mumbai headquartered Glenmark Pharmaceuticals Ltd. has announced that its Suisse subsidiary, Glenmark Specialty S.A., has entered into an exclusive licensing agreement with Yuhan Corporatio...Read more

SEG101 therapy by Novartis gets FDA approval

Company |  News | 0 Comment | 09 Jan, 2019

Novartis has announced that the US Food and Drug Administration has granted crizanlizumab (SEG101) Breakthrough Therapy designation for the prevention of vaso-occlusive crises (VOCs) in pat...Read more

Zydus receives final USFDA approval for antipsychotic drug

Company |  News | 0 Comment | 09 Jan, 2019

Zydus Cadila has received the final approval from the USFDA to market Aripiprazole Tablets USP (US RLD – Abilify) in the strengths of 2 mg, 5 mg, 10 mg, 15 mg, 20 mg, and 30 mg. It w...Read more

Holmusk gets residency of Johnson & Johnson Innovation

Company |  News | 0 Comment | 08 Jan, 2019

Holmusk became a resident company of Johnson & Johnson Innovation, JLABS (JLABS @ NYC), a premier life science incubator program. With its residency, Holmusk is excited to interact...Read more

NaMuscla from Lupin receives EC Approval

Company |  News | 0 Comment | 08 Jan, 2019

Lupin has announced that the European Commission has approved NaMuscla® (mexiletine) for the symptomatic treatment of myotonia in adults with non-dystrophic myotonic (NDM) disorders. N...Read more

Lupin Pharma issues voluntary recall of Ceftriaxone for Injection

Company |  News | 0 Comment | 07 Jan, 2019

Lupin Pharmaceuticals is voluntarily recalling 5 lots of Ceftriaxone for Injection, USP, 250mg, 10 lots of Ceftriaxone for Injection, USP, 500mg, 24 lots of Ceftriaxone for Injection, USP, ...Read more

Lupin receives FDA approval for Lurasidone Hydrochloride Tablets

Company |  News | 0 Comment | 07 Jan, 2019

Pharma major Lupin has announced that it has received approval for its Lurasidone Hydrochloride Tablets, 20 mg, 40 mg, 60 mg, 80 mg & 120 mg from the United States Food and Drug Adminis...Read more

every sixth person with respiratory disease lives in India: Cipla

Company |  News | 0 Comment | 04 Jan, 2019

Respiratory diseases are the second leading cause of death in the population aged 25 – 69 years in India. Worldwide, asthma is the second most common respiratory condition after ...Read more

HealthCare atHOME receives GPW Certification

Company |  News | 0 Comment | 04 Jan, 2019

HealthCare atHOME (HCAH) has announced that it has been certified as a great workplace by the independent analysts at Great Place to Work®. HCAH earned this credential based on extensi...Read more